This study is accepting new patients by invitation only
Open Label Extension (OLE) Study of the Safety and Clinical Utility of IPX203 in PD Patients With Motor Fluctuations
Summary
- Eligibility
- for people ages 40 years and up (full criteria)
- Location
- at Irvine, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Impax Laboratories, LLC
- ID
- NCT03877510
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated